Ubs Asset Management Americas Inc Vera Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 80,106 shares of VERA stock, worth $2.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,106
Previous 61,574
30.1%
Holding current value
$2.74 Million
Previous $2.72 Million
24.52%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.8MCall Options Held
78.4KPut Options Held
89.8K-
Avoro Capital Advisors LLC New York, NY5.61MShares$192 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$150 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$114 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$101 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$101 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $924M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...